A digital medicine company that


The Future of Digital Medicine

SMARTTAB PLATFORM

Product Roadmap

TargetTab™

TargetTabIconLogo3

SmartTab's oral capsule for colon targeted drug delivery. Designed specifically for targeted delivery of medication.


Successfully Completed PK Pre-clinical Animal Studies in 2019. Preparing for Human Clinical Studies to begin Q4 2020. FDA submission Q2 2021. Anticipated FDA approval/clearance Q4 2021. Commercialization of prescription drug 2022.

InjectTab™

InjectTabIconLogo

SmartTab's oral injection capsule for biologics and large molecules. Making injections with needles a thing of the past.


Preparing PK Pre-clinical Animal Studies in a  significant strategic partnership with a large pharmaceutical company begins Q3 2020. Human Clinical Studies to begin Q1 2021. FDA submission Q4 2021. Anticipated FDA approval/clearance and commercialization of prescription drug 2023. 

MultiTab™

MultiTabIconLogo

SmartTab's multi-compartment capsule to reside in the stomach for a week with active ingredients to release each day.


Early design and prototyping complete. PK Pre-clinical Animal Studies to begin Q2 2021. Human Clinical Studies Q4 2021. FDA submission Q2 2022. Anticipated FDA approval/clearance and commercialization of prescription drug 2024. 

WIRELESS TECHNOLOGY

Meets Drug Delivery

InductivePower

Inductive Power

The SmartTab platform utilizes inductive power (no on-board batteries) and proprietary innovative smart polymer technology for the actuation and release system. We continue to advance the capabilities of wireless power for the future of digital medicine.

Realtime

Real-time Monitoring

The SmartTab platform connects with a smartphone or smartwatch via bluetooth RF signal to monitor when the capsule has reached the desired location. Monitoring for statistical based therapy optimization. Real-time decision making and wireless drug delivery.

Target2

Targeted Medicine

We are developing superior drug delivery mechanisms. Using technology for an advanced drug delivery system that target's precise locations in the GI tract. When the triggering signal is sent, it releases immediately for better drug efficacy and better patient outcomes.

Rx2

Increased Drug Compliance

One of the biggest problems with treatments today is compliance. With the SmartTab electronic system triggering the release, the physician knows whether the patient is adhering to the prescribed drug treatment regimen.

PillOpen

Lower Toxicity

By having a very specific targeted delivery system we can negate the negative side effects associated with the medicine and will be able to use lower dosages. Lower dosages means lower side effects and improved patient outcomes.

cloud3

Internet of Medical Things (IoMT)

Integration with IoMT. Data can be sent into artificial intelligence and then optimize the treatment. The SmartTab platform will integrate with other systems as the future of digital health evolves.

TargetTabFeature

A Clear Path to Commercialization

TargetTab™ an ingestible capsule for wireless, targeted drug delivery. The first application of the SmartTab Platform for Crohn's and other GI related diseases. 

SEE OUR PROGRESS

SAY HELLO TO

Our Team

 

Robert Niichel
Founder & CEO
Douglas Miller, PhD
Chief Technology Officer
Dr. Douglas Miller has over 25 years of experience in the medical device field including academic research, multi-national corporate R&D, as well as playing key roles in three previous start-ups where he was involved in founding and commercialization. Doug has more than 20 years experience in active implantable devices and over 5 years in in-vitro diagnostics and pharmaceuticals. He has led engineering, R&D, manufacturing, quality, and regulatory functions at the VP and director level, taking products from inception to market. He also holds nine patents in the biomedical field. Doug is a published author with a BS in Electrical Engineering and an MS & PhD in Electrical/Biomedical Engineering.
Dr. Mark Brunvand
Chief Medical Officer & Clinical Director
Philip Bien
Senior Engineer
 
Sacha Heppell
Chief Marketing Officer

Recap of Startup Health Festival 🚀 and J.P. Morgan Week 2020

Startup Health Festival and J.P.  Morgan Healthcare Week 2020     I turn the corner to Market Street and see the bright yellow Startup Health Festival sign. Walk in and there's 105 entrepreneurs all...

SmartTab to Present Significant Progress at Startup Health Festival in January 2020

The SmartTab team is pleased to announce they will be attending the Startup Health Festival 2020 in San Francisco to present significant progress on the Wireless Ingestible Capsule. 

SmartTab Will Present At The Digital Medicine & Medtech Showcase 2020

SmartTab™ announced that it will be presenting the wireless drug delivery system on January 15th to a crowd of strategic pharmaceutical med tech, med device and institutional companies to discuss the...

SMARTTAB IN

The News

STAY CONNECTED

Contact Us

SmartTab is focused on revolutionizing digital healthcare to optimize patient outcomes, significantly increase prescription drug adherence, and drastically reduce healthcare costs.